Genomic Valley Biotech
₹59.85
-3.15 (-5%)
22 January, 2025 16:21 BSE: 539206
NSE: GVBLISIN: INE574D01010
Start SIP in Genomic Valley Biotech
Start SIPGenomic Valley Biotech Performance
Day Range
52 Week Range
Genomic Valley Biotech Technicals
EMA & SMA
Current Price
₹59.85
-3.15 (-5%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹78.08
- 50 Day
- ₹84.41
- 100 Day
- ₹81.84
- 200 Day
- ₹70.09
- 20 Day
- ₹79.41
- 50 Day
- ₹89.73
- 100 Day
- ₹87.16
- 200 Day
- ₹65.77
Genomic Valley Biotech Resistance and Support
PIVOT
₹62.01
Resistance | |
---|---|
First Resistance | 64.08 |
Second Resistance | 65.16 |
Third Resistance | 67.23 |
RSI | 20.40 |
MFI | 57.77 |
MACD Single Line | -4.35 |
MACD | -6.27 |
Support | |
---|---|
First Support | 60.93 |
Second Support | 58.86 |
Third Supoort | 57.78 |
Genomic Valley Biotech Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 7,828 | 782,800 | 100 |
Week | 1,735 | 173,520 | 100 |
1 Month | 3,471 | 275,061 | 79.24 |
6 Month | 13,194 | 1,302,558 | 98.72 |
Genomic Valley Biotech Result Highlights
Genomic Valley Biotech Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Genomic Valley Biotech Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-12-06 | Others | Inter alia - To consider and Approve (1) The Directors Report for the Year 2023-24. (2) 30th AGM of the Company and Other Business Matters. |
2024-10-07 | Quarterly Results | |
2024-07-29 | Quarterly Results | |
2024-05-09 | Audited Results | |
2024-02-14 | Quarterly Results | (Revised) |